The developers of the vaccine against coronavirus were afraid that in their work the intrusion of politics: the American leader Donald trump can pressure them. This writes The New York Times, citing sources in the White house.
It is noted that the Ministry of health and social services of the United States in April called the best way of dealing with the pandemic of the speedy development of a vaccine against COVID-19. It promised to release by October 2020, which was associated with trump’s desire to “curb the virus” to the presidential election in November. However, the timing had to be postponed: now it is planned to develop millions of doses of vaccine by the end of 2020 or early 2021.
Experts in the government fear that trump may put pressure on Management on sanitary inspection behind quality of foodstuff and medicines (FDA) to expedite the development of drugs. It is necessary to win elections: the President wants to make the vaccine a “surprise” for voters. Experts believe that thus he can ignore the lack of data on the virus and to produce low-quality vaccine.
The New York adds that the American leader really urges developers. So, trump had already visited the biotechnology laboratory in North Carolina, where they promised to release the drug in record time. In addition, he insisted that the FDA “does an excellent job” and have time to develop a drug is “a lot ahead of schedule”. The newspaper argued that it puts pharmaceutical companies in a dead end: they balance between the demands of administration and security reasons, according to which vaccine is better not to release it until it is not checked.
USA, UK, European Union and Japan have already reserved the 1.3 billion doses of vaccines against coronavirus, despite the fact that the current formula has not yet been created. Analysts have expressed concern that doses are not enough for 7.8 billion, and other, less rich countries will be “last in line” to receive the vaccine. Another obstacle to rapid global immunization is that to develop immunity is likely to require not one, but two doses.
The total number of people infected with coronavirus by August 4, exceeded 18.2 million people. The pandemic has covered 188 countries.
